Image

A Natural History Study of Metabolic Sizing in Health and Disease

A Natural History Study of Metabolic Sizing in Health and Disease

Recruiting
2-99 years
All
Phase N/A

Powered by AI

Overview

Background

Scientists have long used simple measures (such as height and weight) to estimate how much a person s body uses food (calories) as energy, as commonly called the metabolic rate. But metabolism varies among people with similar body sizes. Scientists now believe the old formulas for estimating metabolic rates may not work well for all people. Researchers want to find more accurate ways to measure a person s metabolism.

Objective

This natural history study will examine the relationships between metabolism, body composition, and body surface area in a wide range of people.

Eligibility

Healthy children and adults aged 2 years or older. Also, people aged 2 years or older with conditions that may alter metabolism. These may include diabetes, obesity, renal disease, or cancer.

Design

Participants will spend 2 days and 1 night in the hospital. They will provide a medical history and answer questions about their activity levels, the foods they eat, and their lifestyle. They will also eat a special diet.

Participants will undergo many tests:

They will lie in a bed with a clear hood covering their head for 30 to 45 minutes to measure the gases in their breath.

They will lie on a padded table for about 15 minutes while their body is scanned.

They will stand on a platform while a 3D scanner measures their body.

They will have a test to measure how fast an electric signal moves through their body.

They will grip an instrument to measure the strength of their hands.

They will drink salty water and provide blood and urine samples.

Participants may be invited to return for these 2-day visits up to 8 times per year. Return visits must be at least 2 weeks apart.

Description

Study Description:

This study will examine the relationships between comprehensively measured resting energy expenditure (REE), body composition, and body surface area (BSA) in a wide range of healthy and diseased individuals.

Objectives

Primary Objectives:

  • To compare estimated and measured BSA.
  • To determine if measured BSA is associated with REE independent of body composition measures
    Endpoints

Primary Endpoints:

  • Mean difference and limits of agreement at baseline between measured BSA and predicted BSA calculated from traditional biometrics such as height and weight.
  • Increase in R^2 when measured BSA is added to equations predicting REE.

Eligibility

  • INCLUSION CRITERIA:
        In order to be eligible to participate in this study, an individual must meet all the
        following criteria for their cohort:
        Cohort 1 - Healthy Volunteers
          -  Male or female, aged >=2 years
          -  In good general health as evidenced by medical history
        Cohort 2 - Patients
          -  Male or female, aged >=2 years
          -  Diagnosed with diseases thought to alter metabolism or body composition (such as
             weight loss or gain, diabetes, renal disease, obesity, cancer, etc.) or taking
             medications thought to alter metabolism or body composition.
        EXCLUSION CRITERIA:
        An individual who meets any of the following criteria will be excluded from participation
        in this study:
          -  Participants over 200 kg due to the weight limit of the equipment.
          -  Presence of any implanted device that would interfere with measurements.
          -  Any moderate to severe limitations in mobility that would impede participation
          -  Hemoglobin less than 10 g/dL. (in participants who would have blood drawn for research
             purposes)
          -  Participants with dietary allergies, intolerances or eating patterns that would
             preclude them from consuming metabolic meals.
          -  Participants unwilling or unable to give informed consent.
          -  Participants with any other significant physical, medical, or psychiatric limitations,
             illness or conditions that may preclude them from completing the majority of the tests
             in this study per the discretion of the PI.

Study details
    Metabolic Disorders
    Cancer
    Chronic Kidney Disease
    Diabetes
    Normal Physiology

NCT05398783

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

28 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.